These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32980800)

  • 1. Multi-epitope insert modulates solubility-based and chromatographic purification of human papilloma virus 16 L1-based vaccine without inhibiting virus-like particle assembly.
    Saylor K; Waldman A; Gillam F; Zhang C
    J Chromatogr A; 2020 Nov; 1631():461567. PubMed ID: 32980800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
    Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
    Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple and high efficiency purification of His-tagged turnip yellow mosaic virus-like particle (TYMV-VLP) by nickel ion affinity precipitation.
    Tan FH; Ng JF; Mohamed Alitheen NB; Muhamad A; Yong CY; Lee KW
    J Virol Methods; 2023 Sep; 319():114771. PubMed ID: 37437780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.
    Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD
    Virol J; 2012 Feb; 9():52. PubMed ID: 22356831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
    Baek JO; Seo JW; Kim IH; Kim CH
    Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles.
    Kim HJ; Lim SJ; Kwag HL; Kim HJ
    PLoS One; 2012; 7(4):e35893. PubMed ID: 22563414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.
    Lagoutte P; Mignon C; Donnat S; Stadthagen G; Mast J; Sodoyer R; Lugari A; Werle B
    J Virol Methods; 2016 Jun; 232():8-11. PubMed ID: 26947397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
    Schädlich L; Senger T; Gerlach B; Mücke N; Klein C; Bravo IG; Müller M; Gissmann L
    J Virol; 2009 Aug; 83(15):7690-705. PubMed ID: 19457985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
    Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
    Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
    Matić S; Rinaldi R; Masenga V; Noris E
    BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response.
    Bissa M; Zanotto C; Pacchioni S; Volonté L; Venuti A; Lembo D; De Giuli Morghen C; Radaelli A
    Antiviral Res; 2015 Apr; 116():67-75. PubMed ID: 25660110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomavirus-like particle vaccines.
    Schiller JT; Lowy DR
    J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
    Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M
    Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
    Schädlich L; Senger T; Kirschning CJ; Müller M; Gissmann L
    Vaccine; 2009 Mar; 27(10):1511-22. PubMed ID: 19174177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthogonal protein purification facilitated by a small bispecific affinity tag.
    Nilvebrant J; Alm T; Hober S
    J Vis Exp; 2012 Jan; (59):. PubMed ID: 22297419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-step chromatographic purification of glutathione S-transferase-tagged human papillomavirus type 16 E6 protein and its application for serology.
    Xu ML; Kim SC; Kim HJ; Ju W; Kim YH; Kim HJ
    Protein Expr Purif; 2017 Apr; 132():19-26. PubMed ID: 28089881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of recombinant hydantoinase and L-N-carbamoylase from Arthrobacter aurescens expressed in Escherichia coli: comparison of wild-type and genetically modified proteins.
    Pietzsch M; Wiese A; Ragnitz K; Wilms B; Altenbuchner J; Mattes R; Syldatk C
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 737(1-2):179-86. PubMed ID: 10681054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changed loading conditions and lysate composition improve the purity of tagged recombinant proteins with tacn-based IMAC adsorbents.
    Zhang C; Fredericks D; Longford D; Campi E; Sawford T; Hearn MT
    Biotechnol J; 2015 Mar; 10(3):480-9. PubMed ID: 25303209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development a scalable production process for truncated human papillomavirus type-6 L1 protein using WAVE Bioreactor and hollow fiber membrane.
    Sun B; Zhao D; Zhang X; Gu T; Yu X; Sun S; Zhao X; Wei L; Liu D; Yan H; Meng X; Kong W; Xu F; Yang P; Jiang C
    Appl Microbiol Biotechnol; 2016 Feb; 100(3):1231-1240. PubMed ID: 26446387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.